Becton, Dickinson and Company (LON:0R19)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 41.18B |
| Revenue (ttm) | 15.61B |
| Net Income (ttm) | 1.16B |
| Shares Out | n/a |
| EPS (ttm) | 3.99 |
| PE Ratio | 35.59 |
| Forward PE | 13.43 |
| Dividend | 3.15 (1.66%) |
| Ex-Dividend Date | Sep 8, 2025 |
| Volume | 186 |
| Average Volume | 758 |
| Open | 190.65 |
| Previous Close | 189.76 |
| Day's Range | 190.65 - 195.33 |
| 52-Week Range | 163.64 - 251.08 |
| Beta | 0.30 |
| RSI | 60.03 |
| Earnings Date | Nov 6, 2025 |
About LON:0R19
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, LON:0R19's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial numbers in USD Financial StatementsNews
Best Dividend Aristocrats For October 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...
Becton Dickinson (BDX) Partners with Henry Ford Health for Pharmacy Automation
Becton Dickinson (BDX) Partners with Henry Ford Health for Pharmacy Automation
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
FRANKLIN LAKES, N.J. , Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership wit...
BDX Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published strategy...
Fluorescence Cell Market Forecasts USD 6.37 Billion by 2034 at 7.29% CAGR
Fluorescence Cell Market (2024 - 2034) Report by Towards Healthcare, a sister firm of Precedence Research Fluorescence Cell Market (2024 - 2034) Report by Towards Healthcare, a sister firm of Preceden...
Becton, Dickinson and Company (BDX) Secures $2.75 Billion Revolving Credit Facility
Becton, Dickinson and Company (BDX) Secures $2.75 Billion Revolving Credit Facility
BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics
FRANKLIN LAKES, N.J. , Sept. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ S...
BD (BDX) Expands Alaris Pump Recall, Adds 15 More Infusion Sets
BD (BDX) Expands Alaris Pump Recall, Adds 15 More Infusion Sets
Peter Lynch Detailed Fundamental Analysis - BDX
Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published strategy...
Insider Sell: Claire Fraser Sells Shares of Becton Dickinson & Co (BDX)
Insider Sell: Claire Fraser Sells Shares of Becton Dickinson & Co (BDX)
Ex-Dividend Reminder: Alphabet, Becton, Dickinson And Rogers
On 9/8/25, Alphabet, Becton, Dickinson, and Rogers Communications will all trade ex-dividend for their respective upcoming dividends. Alphabet will pay its quarterly dividend of $0.21 on 9/15/25, Bect...
Becton, Dickinson And Company (BDX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
FRANKLIN LAKES, N.J. , Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a serio...
Best Dividend Aristocrats For September 2025
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...
Best Dividend Kings: August 2025
Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August, with several stocks achieving double-digit returns in 2025. Fifteen Dividend Kings currently appear undervalued...
Becton, Dickinson: Great Time To Buy This Dividend Aristocrat
11 Dividend Aristocrats With Excellent Upside Potential In The Next Year
Dividend Growth Outperformance: For over 50 years, dividend growers have delivered market-beating returns with lower volatility. The BTI Example: British American Tobacco went from six years of stagna...
BD to Present at Wells Fargo 2025 Healthcare Conference
FRANKLIN LAKES, N.J. , Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Farg...
Heartland's 3 Tactical Q2 Moves: Trimming Risk, Harvesting Losses, And Raising Cash
We remain patient and opportunistic, raising cash to capitalize on future volatility and focusing on stocks meeting our 10 Principles of Value Investing™. We initiated a position in Applied Materials,...
Becton Dickinson Q3 Beats Estimates On Medical Device Boom
As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company BDX are reporting robust financial performances that highlight their resilience a...
Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Christopher J. DelOrefice - Executive VP & CFO Greg Rodetis - Senior VP, Treasurer & Head...
Becton Dickinson joins peer in raising annual profit forecast after results beat
Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.
BD Reports Third Quarter Fiscal 2025 Financial Results
Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organic GAAP and adjusted diluted EPS grew to $2.00 and $3.68, respectively GAAP and adjusted gross margin up 160 basis ...
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
FRANKLIN LAKES, N.J. , Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC...
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care
FRANKLIN LAKES, N.J. , Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million a...